Search

everythinglearnresearchcommunity

for

Search:↓

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Human hair proteins can help blood clot when mixed in equal parts.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Scientists made antibodies to tell cashmere and wool apart, which could improve how we identify animal fibers.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

Immunological treatment improved both neuropathy and alopecia.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Adding a second method to PROTACs could improve cancer treatment.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Imuvert can prevent some chemotherapy-induced hair loss.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Infliximab may cause hair loss in Crohn's disease patients.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Blood count parameters are not reliable for predicting recurrent implantation failure.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.